Drug Shortage Report for PMS-ROSUVASTATIN
| Report ID | 7500 |
| Drug Identification Number | 02378558 |
| Brand name | PMS-ROSUVASTATIN |
| Common or Proper name | ROSUVASTATIN |
| Company Name | PHARMASCIENCE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ROSUVASTATIN |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 |
| ATC code | C10AA |
| ATC description | LIPID MODIFYING AGENTS, PLAIN |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2017-05-18 |
| Actual start date | 2017-05-18 |
| Estimated end date | 2018-04-29 |
| Actual end date | 2018-04-17 |
| Shortage status | Resolved |
| Updated date | 2018-04-19 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.